Call for Abstract

Scientific Program

3^rd International Conference on Cancer Biology and Therapeutics, will be organized around the theme “Advancing Cancer Research: Innovations in Biology and Therapeutic Solutions”

CANCER BIOLOGY- 2025 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in CANCER BIOLOGY- 2025

Submit your abstract to any of the mentioned tracks.

Track 1:Cancer Biology

Cancer Biology focuses on understanding the mechanisms that drive cancer development, progression, and metastasis. It delves into the genetic, cellular, and molecular aspects of cancer, including the role of oncogenes, tumor suppressor genes, and cell cycle dysregulation. The track also explores immune evasion strategies and the interactions between tumor cells and the surrounding microenvironment that contribute to cancer's aggressive nature. By investigating the fundamental processes of cancer biology, this track aims to uncover novel targets for therapeutic intervention and improve the molecular understanding of cancer.

Track 2:Molecular Biology of Cancer

Molecular Biology of Cancer explores the genetic and epigenetic alterations that drive cancer initiation and progression. This track covers gene mutations, chromosomal abnormalities, and the molecular pathways that regulate cancer development. It also examines the role of microRNAs, DNA repair mechanisms, and epigenetic modifications in tumor malignancy and resistance to therapies. By understanding these molecular mechanisms, the track aims to uncover new insights for improving cancer diagnosis, identifying novel biomarkers, and developing more effective treatment strategies.

Track 3:Cancer Genomics and Epigenetics

Cancer Genomics and Epigenetics investigates the genetic and epigenetic alterations that drive tumorigenesis. This track explores the role of DNA methylation, histone modifications, and non-coding RNAs in cancer development. It also covers advanced technologies like next-generation sequencing and CRISPR, providing insights into how genomic and epigenetic changes influence cancer biology. By understanding these alterations, the track aims to advance cancer research and contribute to the development of more precise diagnostic tools and targeted therapies, ultimately improving treatment strategies and patient outcomes.

Track 4:Tumor Microenvironment

Tumor Microenvironment investigates the tumor microenvironment (TME) and its critical role in cancer progression, therapy resistance, and metastasis. Topics include angiogenesis, hypoxia, immune system interactions, and metabolic reprogramming within the TME. Understanding how the TME influences cancer biology will help in developing therapeutic strategies targeting the microenvironment to improve treatment efficacy and overcome resistance.

Track 5:Innovations in Cancer Research

Innovations in Cancer Research highlights groundbreaking advancements in cancer research, including new approaches in cancer diagnosis, treatment, and drug discovery. Key topics include targeted therapies, immunotherapy, and CRISPR gene-editing technologies. The track also explores the role of artificial intelligence in enhancing cancer research and clinical decision-making, aiming to improve patient outcomes through innovative therapeutic strategies.

Track 6:Cancer Immunology and Immunotherapy

Cancer Immunology and Immunotherapy examines the complex relationship between cancer and the immune system, focusing on mechanisms of immune evasion and the latest immunotherapy advancements. Topics include checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, and strategies to overcome resistance to immunotherapy. This track emphasizes improving the effectiveness of immune-based treatments to enhance cancer patient outcomes by boosting immune responses and addressing therapeutic challenges. The goal is to explore innovative ways to harness the immune system’s power to fight cancer more effectively.

Track 7:Cancer Stem Cells and Therapeutics

Cancer Stem Cells and Therapeutics investigates the role of cancer stem cells (CSCs) in tumor growth, metastasis, and resistance to conventional treatments. CSCs are responsible for recurrence and therapy resistance, making them critical targets for effective cancer therapies. This track focuses on innovative strategies to target CSCs, including novel drugs, immunotherapies, and gene-editing techniques. By exploring new approaches to eliminate CSCs, the aim is to prevent tumor recurrence and metastasis, leading to more effective and long-lasting treatments for cancer patients.

Track 8:Biomarkers and Liquid Biopsy

Biomarkers and Liquid Biopsy focuses on the use of biomarkers for cancer detection, prognosis, and monitoring. This track emphasizes liquid biopsy as a non-invasive method for early cancer detection, offering advantages over traditional tissue biopsies. Liquid biopsy analyzes circulating tumor cells, DNA, RNA, and exosomes in bodily fluids like blood, enabling personalized treatment strategies. By identifying genetic alterations and monitoring tumor dynamics, liquid biopsy aids in tailoring therapies and tracking treatment response, thus improving patient outcomes and reducing the need for invasive procedures.

Track 9:Cancer Pharmacology and Drug Development

Cancer Pharmacology and Drug Development examines the mechanisms of action and metabolism of anticancer drugs, focusing on new drug classes, small molecules, biologics, and antibody-drug conjugates. It highlights novel drug delivery systems and explores strategies to overcome resistance mechanisms and enhance drug efficacy. The track aims to provide insights into the development of new cancer therapies to improve patient outcomes.

Track 10:Cancer Stem Cells and Therapeutics

Cancer Stem Cells and Therapeutics examines the role of cancer stem cells (CSCs) in tumor growth, metastasis, and resistance to conventional therapies. This track focuses on current research into CSC-targeting treatments, exploring novel drugs and strategies designed to eliminate CSCs. By targeting these cells, which are responsible for tumor recurrence and metastasis, the track aims to develop more effective therapies, offering hope for improved treatment outcomes and long-term cancer remission.

Track 11:Biomarkers and Liquid Biopsy

Biomarkers and Liquid Biopsy focuses on the discovery and validation of biomarkers for cancer detection and monitoring treatment. This track emphasizes the role of liquid biopsy as a non-invasive tool for early cancer detection. By analyzing circulating tumor cells, DNA, RNA, and exosomes, liquid biopsy enables accurate prognosis and facilitates personalized treatment strategies. The track aims to enhance diagnostic accuracy and treatment effectiveness, offering a promising approach for continuous monitoring of cancer progression and response to therapy.

Track 12:Oncologic Imaging and Diagnostics

Oncologic Imaging and Diagnostics covers the latest advancements in oncologic imaging and diagnostic techniques, including PET-CT, MRI, molecular imaging, and radiomics. It explores how artificial intelligence and next-generation sequencing are enhancing tumor characterization and patient monitoring, providing insights into how these technologies can improve cancer diagnosis, treatment planning, and outcomes.

Track 13:Artificial Intelligence in Cancer Research

Artificial Intelligence in Cancer Research explores the transformative role of AI in cancer research and clinical applications. This track focuses on using AI for tumor classification, drug discovery, and predictive modeling to improve diagnosis and treatment outcomes. It also addresses the ethical considerations of integrating AI into healthcare systems, emphasizing the need for responsible use of technology in clinical settings. By harnessing AI, the track aims to enhance precision medicine and accelerate breakthroughs in cancer treatment.

Track 14:Cancer Epidemiology and Public Health

Cancer Epidemiology and Public Health explores global cancer trends, risk factors, and lifestyle influences. This track addresses the environmental and genetic factors contributing to cancer development and emphasizes cancer prevention through public health measures, including early detection programs, vaccination initiatives, and education on reducing cancer risk factors such as smoking, diet, and physical inactivity.

Track 15:Cancer Vaccines and Preventive Strategies

Cancer Vaccines and Preventive Strategies focuses on the development of therapeutic and preventive cancer vaccines, including promising new approaches like mRNA vaccines, dendritic cell-based vaccines, and oncolytic viruses. It also explores the role of vaccines in cancer prevention and the implementation of public health strategies to reduce cancer incidence through vaccination and other preventive measures.

Track 16:Radiation Therapy

Radiation Therapy focuses on advancements in radiotherapy techniques, including precision radiotherapy and proton therapy. This track explores the integration of AI in treatment planning to enhance precision and effectiveness. It also addresses strategies to minimize side effects while improving patient outcomes, aiming to optimize radiation therapy for better targeting of tumors and reducing damage to healthy tissue. The track seeks to highlight innovative approaches that improve the overall effectiveness and safety of radiation treatments for cancer patients.

Track 17:Cancer Control and Survivorship Care

Cancer Control and Survivorship Care focuses on the ongoing care of cancer survivors, addressing long-term physical and psychological challenges. This track explores rehabilitation, emotional support, and strategies to improve quality of life after treatment. It emphasizes the importance of managing survivorship issues such as fatigue, pain, mental health, and the risk of recurrence, with the goal of enhancing the overall well-being of cancer survivors and helping them navigate life after cancer treatment.

Track 18:Pediatric Oncology

Pediatric Oncology focuses on the unique challenges of diagnosing and treating cancer in children. This track explores the latest advancements in pediatric oncology, including targeted therapies and immunotherapy. It also examines the psychosocial impact of cancer on children and their families, as well as strategies to improve care and quality of life for young patients.

Track 19:Artificial Intelligence in Cancer Research

Artificial Intelligence in Cancer Research highlights the transformative role of artificial intelligence in cancer research and clinical applications. Topics include machine learning algorithms for tumor classification, drug discovery, predictive modeling, and the ethical considerations surrounding AI integration in cancer care. The track emphasizes how AI can enhance precision medicine and accelerate cancer research breakthroughs.